Shareholders’ Equity (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Shareholders’ Equity [Abstract] |
|
| Schedule of Significant Inputs into the Black-Scholes Valuation Model |
The
significant inputs into the Black-Scholes valuation model at the initial recognition date are as follows: | |
| 5.5 Years
June
Warrants |
|
| 2 Years
June
Warrants |
|
| Term |
| |
5.5 years |
|
| |
2 years |
|
| Dividend |
| |
- |
|
| |
- |
|
| Expected volatility |
| |
44.77 |
% |
| |
44.77 |
% |
| Risk-free rate |
| |
3.95 |
% |
| |
4.28 |
% |
| Stock price |
| $ |
19.7 |
|
| $ |
19.7 |
|
2 year July Warrants:
| |
| 2 Years
July
Warrants |
|
| Term |
| |
2 years |
|
| Dividend |
| |
- |
|
| Expected volatility |
| |
61.60 |
% |
| Risk-free rate |
| |
3.86 |
% |
| Stock price |
| $ |
16.5 |
|
The significant inputs into the Black-Scholes valuation model at the initial recognition date are as follows: | |
| 5 Years
Sep
Warrants |
|
| 2 Years
Sep
Warrants |
|
| Term |
| |
5 years |
|
| |
2 years |
|
| Dividend |
| |
- |
|
| |
- |
|
| Expected volatility |
| |
73.91 |
% |
| |
190 |
% |
| Risk-free rate |
| |
3.71 |
% |
| |
3.58 |
% |
| Stock price |
| $ |
0.4322 |
|
| $ |
0.4322 |
|
|
| Schedule of Outstanding Warrants |
Total outstanding warrants as of December
31, 2025, are as follow:
| |
|
Number of
warrants |
|
|
Exercise
price |
|
|
Period left
in years |
|
| Warrants May 2023 |
|
|
6,613 |
|
|
$ |
46.25 |
|
|
|
1.5 |
|
| Warrants December 2023 |
|
|
8,899 |
|
|
$ |
14.75 |
|
|
|
3 |
|
| Warrants June 2024 |
|
|
6,998 |
|
|
$ |
34.375 |
|
|
|
3.9 |
|
| Warrants July 2024 |
|
|
6,998 |
|
|
$ |
25 |
|
|
|
0.5 |
|
| Warrants July 2025 |
|
|
499,188 |
|
|
$ |
6.2-$7.7 |
|
|
|
2.42 |
|
| Warrants September 2025 |
|
|
670,421 |
|
|
$ |
3.7-$4.6 |
|
|
|
3.36 |
|
| Warrants October 2025 |
|
|
10,000 |
|
|
$ |
3.7 |
|
|
|
4.7 |
|
| Warrants December 2025 |
|
|
6,687,500 |
|
|
$ |
0.8-$1
|
|
|
|
5 |
|
| Other |
|
|
3,679 |
|
|
$ |
102.7 - $500 |
|
|
|
0.6 – 1.5 |
|
| Outstanding as of December 31, 2025 |
|
|
7,900,296 |
|
|
|
|
|
|
|
|
|
|
| Schedule of Awards Granted |
During the years ended December 31, 2025, and December 2024, the following awards were granted: | Award Type (2025 Plan) |
| Number
of Awards |
|
| Vesting Conditions |
| Expiration Date |
| RSU |
| |
173,250 |
|
| Over 3 years from grant date |
| 10th anniversary of Grant Date |
|
| Schedule of Share Options, Granted to Employees, Directors, Under Option Plans |
A summary of the Company’s share options, granted to employees, directors, under option plans is as follows: | | | Number of
Options | | | Weighted-
Average
Exercise
Price | | | Weighted
Average
Remaining
Contractual
Life | |
| Outstanding – January 1, 2025 | | | 6,268 | | | $ | 43.8 | | | | 3 | |
| Granted | | | - | | | $ | | | | | | |
| Exercised | | | - | | | $ | | | | | | |
| Forfeited | | | (2,311 | ) | | $ | 7.5 | | | | | |
| | | | | | | | | | | | | |
| Outstanding – December 31, 2025 | | | 3,957 | | | $ | 36.3 | | | | 1.3 | |
| | | | | | | | | | | | | |
| Exercisable – December 31, 2025 | | | 3,853 | | | $ | 35 | | | | 1.3 | |
|
| Schedule of Number of Ordinary Shares Issuable Upon Outstanding Options and Exercisable Options |
The following table summarize information as of December 31, 2025, regarding the number of ordinary shares issuable upon outstanding options and exercisable options: | Exercise price | | Options
outstanding as of
December 31,
2025 | | | Weighted
average
remaining
contractual
life (years) | | | Options
exercisable as of
December 31,
2025 | | | Weighted
average
remaining
contractual
life (years) | |
| 6.4 | | | 283 | | | | 0.02 | | | | 283 | | | | 0.02 | |
| 10.6 | | | 2,553 | | | | 1.72 | | | | 2,553 | | | | 1.72 | |
| 14.8 | | | 40 | | | | 0.08 | | | | 30 | | | | 0.06 | |
| 57.8 | | | 300 | | | | 0.53 | | | | 225 | | | | 0.41 | |
| 136.2 | | | 393 | | | | 0.54 | | | | 393 | | | | 0.54 | |
| 400.0 | | | 388 | | | | 0.66 | | | | 369 | | | | 0.64 | |
| | | | 3,957 | | | | | | | | 3,853 | | | | | |
| Exercise price |
| Options
outstanding as of
December 31,
2024 |
|
| Weighted
average
remaining
contractual
life (years) |
|
| Options
exercisable as of
December 31,
2024 |
|
| Weighted
average
remaining
contractual
life (years) |
|
| 6.4 |
| |
2,459 |
|
| |
0.61 |
|
| |
2,459 |
|
| |
0.61 |
|
| 10.6 |
| |
2,594 |
|
| |
3.6 |
|
| |
2,594 |
|
| |
3.60 |
|
| 14.8 |
| |
40 |
|
| |
8.71 |
|
| |
20 |
|
| |
8.71 |
|
| 57.8 |
| |
400 |
|
| |
5.98 |
|
| |
250 |
|
| |
4.79 |
|
| 136.2 |
| |
389 |
|
| |
6.41 |
|
| |
383 |
|
| |
6.41 |
|
| 400.0 |
| |
386 |
|
| |
7.69 |
|
| |
267 |
|
| |
7.67 |
|
| |
| |
6,268 |
|
| |
|
|
| |
5,973 |
|
| |
|
|
|
| Schedule of RSUs Activity under Option Plans |
A summary of the Company’s RSUs activity under option plans
is as follows:
| |
|
Year ended
December 31, 2025 |
|
| |
|
Number of
RSUs |
|
|
Weighted-
Average
Grant
Date Fair
Value |
|
| RSUs outstanding at the beginning of the year |
|
|
3,625 |
|
|
$ |
123.8 |
|
| Granted during the year |
|
|
173,250 |
|
|
|
4.36 |
|
| Vested during the year |
|
|
(3,168 |
) |
|
|
123.8 |
|
| Forfeited during the year |
|
|
(234 |
) |
|
|
123.8 |
|
| Outstanding at the end of the year |
|
|
173,473 |
|
|
|
4.36 |
|
|
| Schedule of Share-Based Compensation Expense for Share Options |
Share-based compensation expense for RSUs
in the consolidated statement of comprehensive loss is summarized as follows:
| |
|
Year Ended
December 31 |
|
| |
|
2025 |
|
|
2024 |
|
| |
|
U.S. dollars in thousands |
|
| Cost of revenues |
|
|
10 |
|
|
|
10 |
|
| Research and development |
|
|
18 |
|
|
|
18 |
|
| Sales and marketing |
|
|
49 |
|
|
|
36 |
|
| General and administrative |
|
|
220 |
|
|
|
259 |
|
| Total Share-based compensation expense |
|
|
297 |
|
|
|
323 |
|
|